A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (rg7713) in high-functioning adults with autism spectrum disorder
- Daniel Umbricht
- , Marta Del Valle Rubido
- , Eric Hollander
- , James T. McCracken
- , Frederick Shic
- , Lawrence Scahill
- , Jana Noeldeke
- , Lauren Boak
- , Omar Khwaja
- , Lisa Squassante
- , Christophe Grundschober
- , Heidemarie Kletzl
- , Paulo Fontoura
Research output: Contribution to journal › Article › peer-review
63
Link opens in a new tab
Scopus
citations